At DynPort, we're helping the government protect soldiers and civilians against emerging diseases and possible bioterror threats. We're doing important work, protecting our nation's health and security.
Maybe you'd like to learn more about how we can work together:
|Government clients can rest assured that DynPort delivers. We have successfully managed large, complex medical countermeasure development government contracts since 1997, including a botulinum neurotoxin vaccine and plague vaccine.|
|Biotech and pharma companies can rely on DynPort for experienced program management, and guidance through the complex government contracting process, for both business and technical support. We're also always looking for new technology partners.|
|Biodefense colleagues can look to DynPort for regulatory and nonclinical strategy (134K, PDF) support for FDA Animal Rule submissions, and industry news updates.
|Service providers can register to be notified of upcoming opportunities to support DynPort's research and clinical trials. Feel free to contact us to discuss the possibilities.|
|Small businesses can register with our parent company, CSC, to be considered for future opportunities, or learn more about what we need.|
|Smart people who want to make a difference (and occasionally have some fun) can work with us.|
Want to know more about us? Check out our new company profile (PDF, 432K)--it's an infographic!
Still not sure how we can help? Send us a note, and we'll point you in the right direction.
Wondering what other people want to know about us? Check out our frequently asked questions.
DynPort has been developing medical countermeasures for U.S. Government agencies for more than a decade. Read some lessons we've learned along the way.
Why DynPort? Because we know you can't afford to pay for a learning curve.
Stay in touch with us, and get the latest industry and government contracting news delivered to your inbox.